Soligenix, Inc. Files 8-K Report
Ticker: SNGX · Form: 8-K · Filed: Jul 31, 2025 · CIK: 812796
| Field | Detail |
|---|---|
| Company | Soligenix, Inc. (SNGX) |
| Form Type | 8-K |
| Filed Date | Jul 31, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, filing, company-update
TL;DR
SOLIGENIX files 8-K, check for new docs.
AI Summary
On July 31, 2025, Soligenix, Inc. filed an 8-K report. The filing primarily serves as a notification of other events and includes financial statements and exhibits. The company, previously known as DOR BIOPHARMA INC, ENDOREX CORP, and IMMUNOTHERAPEUTICS INC, is incorporated in Delaware and headquartered in Princeton, NJ.
Why It Matters
This 8-K filing indicates that Soligenix, Inc. is providing updated information and exhibits to the SEC, which could contain material developments for investors.
Risk Assessment
Risk Level: low — This filing is a routine 8-K reporting other events and exhibits, not a material event like an acquisition or earnings miss.
Key Players & Entities
- Soligenix, Inc. (company) — Filer of the 8-K report
- DOR BIOPHARMA INC (company) — Former company name
- ENDOREX CORP (company) — Former company name
- IMMUNOTHERAPEUTICS INC (company) — Former company name
- July 31, 2025 (date) — Date of earliest event reported
FAQ
What is the primary purpose of this 8-K filing for Soligenix, Inc.?
The primary purpose of this 8-K filing is to report 'Other Events' and to include 'Financial Statements and Exhibits' as of July 31, 2025.
What are the previous names of Soligenix, Inc. mentioned in the filing?
The filing mentions that Soligenix, Inc. was formerly known as DOR BIOPHARMA INC, ENDOREX CORP, and IMMUNOTHERAPEUTICS INC.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on July 31, 2025.
Where is Soligenix, Inc. incorporated and what is its business address?
Soligenix, Inc. is incorporated in Delaware and its business address is 29 Emmons Drive, Suite B-10, Princeton, NJ 08540.
What is the SIC code for Soligenix, Inc.?
The Standard Industrial Classification (SIC) code for Soligenix, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 31, 2025 regarding SOLIGENIX, INC. (SNGX).